How much does biktarvy cost in ghana 2021?

Is there a fixed price for Biktarvy in Ghana?
No public list price exists for the drug in Ghana. Prices for branded antiretroviral therapies are usually set through negotiated contracts between the Ghana Health Service and the manufacturer, and the details are not published online.

How can a patient or provider learn the actual cost?
The Ghana Health Service publishes a list of prices for drugs under the National Health Insurance Scheme (NHIS). Patients can check the NHIS drug catalogue or contact their local health facility for the latest quotation. The manufacturer, Gilead Sciences, also offers a patient assistance program in some countries; Ghanaian patients may need to apply through a local pharmacy or hospital.

Does the National Health Insurance cover Biktarvy?
Biktarvy is typically not listed in the standard NHIS drug panel for HIV treatment in Ghana. Patients who qualify for the NHIS may still receive coverage for other antiretroviral drugs, but they will usually need to pay out‑of‑pocket for Biktarvy or use a private insurance plan.

What about availability and import restrictions?
Biktarvy is approved for use in Ghana, but its availability is limited to a handful of major pharmacies and hospitals. Importation is governed by the Ghana Food and Drugs Authority (FDA), which requires a valid license and documentation from the pharmacy or hospital.

How does the cost compare to other countries?
In the United States, Biktarvy sells for about $3,200 per month. In many low‑ and middle‑income countries, the price is usually lower, often around 40–60 % of the U.S. price due to generic competition or price‑setting agreements. Exact Ghanaian figures are not publicly reported, so the price could fall within that range, but local negotiations may shift it higher or lower.

Sources
1. https://www.drugpatentwatch.com